NOVEL GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS: A COMPREHENSIVE REVIEW

Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a valuable class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, enhancing insulin secretion and inhibiting glucagon release. Recent investigations have yielded a extensive range of novel GLP-1 receptor agonists

The United States boasts a wide number of manufacturers specializing in the production of Tirzepatide APIs. These companies play a crucial role in supplying this innovative drug substance to pharmaceutical companies. Tirzepatide, a groundbreaking therapy, has garnered significant recognition for its effectiveness in managing type 2 diabetes. As a